161 related articles for article (PubMed ID: 37881876)
1. Dysregulation of the WNK4-SPAK/OSR1 pathway has a minor effect on baseline NKCC2 phosphorylation.
Maeoka Y; Nguyen LT; Sharma A; Cornelius RJ; Su XT; Gutierrez MR; Carbajal-Contreras H; Castañeda-Bueno M; Gamba G; McCormick JA
Am J Physiol Renal Physiol; 2024 Jan; 326(1):F39-F56. PubMed ID: 37881876
[TBL] [Abstract][Full Text] [Related]
2. Combined Kelch-like 3 and Cullin 3 Degradation is a Central Mechanism in Familial Hyperkalemic Hypertension in Mice.
Maeoka Y; Ferdaus MZ; Cornelius RJ; Sharma A; Su XT; Miller LN; Robertson JA; Gurley SB; Yang CL; Ellison DH; McCormick JA
J Am Soc Nephrol; 2022 Mar; 33(3):584-600. PubMed ID: 35064051
[TBL] [Abstract][Full Text] [Related]
3. Arginine vasopressin regulates the renal Na
Carbajal-Contreras H; Murillo-de-Ozores AR; Magaña-Avila G; Marquez-Salinas A; Bourqui L; Tellez-Sutterlin M; Bahena-Lopez JP; Cortes-Arroyo E; Behn-Eschenburg SG; Lopez-Saavedra A; Vazquez N; Ellison DH; Loffing J; Gamba G; Castañeda-Bueno M
Am J Physiol Renal Physiol; 2024 Feb; 326(2):F285-F299. PubMed ID: 38096266
[TBL] [Abstract][Full Text] [Related]
4. SPAK and OSR1 play essential roles in potassium homeostasis through actions on the distal convoluted tubule.
Ferdaus MZ; Barber KW; López-Cayuqueo KI; Terker AS; Argaiz ER; Gassaway BM; Chambrey R; Gamba G; Rinehart J; McCormick JA
J Physiol; 2016 Sep; 594(17):4945-66. PubMed ID: 27068441
[TBL] [Abstract][Full Text] [Related]
5. WNK4 is indispensable for the pathogenesis of pseudohypoaldosteronism type II caused by mutant KLHL3.
Susa K; Sohara E; Takahashi D; Okado T; Rai T; Uchida S
Biochem Biophys Res Commun; 2017 Sep; 491(3):727-732. PubMed ID: 28743496
[TBL] [Abstract][Full Text] [Related]
6. SPAK deficiency corrects pseudohypoaldosteronism II caused by WNK4 mutation.
Chu PY; Cheng CJ; Wu YC; Fang YW; Chau T; Uchida S; Sasaki S; Yang SS; Lin SH
PLoS One; 2013; 8(9):e72969. PubMed ID: 24039833
[TBL] [Abstract][Full Text] [Related]
7. Mutant Cullin 3 causes familial hyperkalemic hypertension via dominant effects.
Ferdaus MZ; Miller LN; Agbor LN; Saritas T; Singer JD; Sigmund CD; McCormick JA
JCI Insight; 2017 Dec; 2(24):. PubMed ID: 29263298
[TBL] [Abstract][Full Text] [Related]
8. Decreased KLHL3 expression is involved in the activation of WNK-OSR1/SPAK-NCC cascade in type 1 diabetic mice.
Guo Q; Zhang Y; Jiang GR; Zhang C
Pflugers Arch; 2021 Feb; 473(2):185-196. PubMed ID: 33432425
[TBL] [Abstract][Full Text] [Related]
9. Novel mechanisms of Na+ retention in obesity: phosphorylation of NKCC2 and regulation of SPAK/OSR1 by AMPK.
Davies M; Fraser SA; Galic S; Choy SW; Katerelos M; Gleich K; Kemp BE; Mount PF; Power DA
Am J Physiol Renal Physiol; 2014 Jul; 307(1):F96-F106. PubMed ID: 24808538
[TBL] [Abstract][Full Text] [Related]
10. A novel Ste20-related proline/alanine-rich kinase (SPAK)-independent pathway involving calcium-binding protein 39 (Cab39) and serine threonine kinase with no lysine member 4 (WNK4) in the activation of Na-K-Cl cotransporters.
Ponce-Coria J; Markadieu N; Austin TM; Flammang L; Rios K; Welling PA; Delpire E
J Biol Chem; 2014 Jun; 289(25):17680-8. PubMed ID: 24811174
[TBL] [Abstract][Full Text] [Related]
11. The CUL3-KLHL3 E3 ligase complex mutated in Gordon's hypertension syndrome interacts with and ubiquitylates WNK isoforms: disease-causing mutations in KLHL3 and WNK4 disrupt interaction.
Ohta A; Schumacher FR; Mehellou Y; Johnson C; Knebel A; Macartney TJ; Wood NT; Alessi DR; Kurz T
Biochem J; 2013 Apr; 451(1):111-22. PubMed ID: 23387299
[TBL] [Abstract][Full Text] [Related]
12. Impaired phosphorylation of Na(+)-K(+)-2Cl(-) cotransporter by oxidative stress-responsive kinase-1 deficiency manifests hypotension and Bartter-like syndrome.
Lin SH; Yu IS; Jiang ST; Lin SW; Chu P; Chen A; Sytwu HK; Sohara E; Uchida S; Sasaki S; Yang SS
Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17538-43. PubMed ID: 21972418
[TBL] [Abstract][Full Text] [Related]
13. WNK bodies cluster WNK4 and SPAK/OSR1 to promote NCC activation in hypokalemia.
Thomson MN; Cuevas CA; Bewarder TM; Dittmayer C; Miller LN; Si J; Cornelius RJ; Su XT; Yang CL; McCormick JA; Hadchouel J; Ellison DH; Bachmann S; Mutig K
Am J Physiol Renal Physiol; 2020 Jan; 318(1):F216-F228. PubMed ID: 31736353
[TBL] [Abstract][Full Text] [Related]
14. Modulation of NCC activity by low and high K(+) intake: insights into the signaling pathways involved.
Castañeda-Bueno M; Cervantes-Perez LG; Rojas-Vega L; Arroyo-Garza I; Vázquez N; Moreno E; Gamba G
Am J Physiol Renal Physiol; 2014 Jun; 306(12):F1507-19. PubMed ID: 24761002
[TBL] [Abstract][Full Text] [Related]
15. Potassium depletion stimulates Na-Cl cotransporter
Ishizawa K; Xu N; Loffing J; Lifton RP; Fujita T; Uchida S; Shibata S
Biochem Biophys Res Commun; 2016 Nov; 480(4):745-751. PubMed ID: 27942049
[TBL] [Abstract][Full Text] [Related]
16. Impaired degradation of WNK1 and WNK4 kinases causes PHAII in mutant KLHL3 knock-in mice.
Susa K; Sohara E; Rai T; Zeniya M; Mori Y; Mori T; Chiga M; Nomura N; Nishida H; Takahashi D; Isobe K; Inoue Y; Takeishi K; Takeda N; Sasaki S; Uchida S
Hum Mol Genet; 2014 Oct; 23(19):5052-60. PubMed ID: 24821705
[TBL] [Abstract][Full Text] [Related]
17. Renal COP9 Signalosome Deficiency Alters CUL3-KLHL3-WNK Signaling Pathway.
Cornelius RJ; Si J; Cuevas CA; Nelson JW; Gratreak BDK; Pardi R; Yang CL; Ellison DH
J Am Soc Nephrol; 2018 Nov; 29(11):2627-2640. PubMed ID: 30301860
[TBL] [Abstract][Full Text] [Related]
18. Roles of WNK4 and SPAK in K
Mukherjee A; Yang CL; McCormick JA; Martz K; Sharma A; Ellison DH
Am J Physiol Renal Physiol; 2021 May; 320(5):F719-F733. PubMed ID: 33719576
[TBL] [Abstract][Full Text] [Related]
19. Constitutively Active SPAK Causes Hyperkalemia by Activating NCC and Remodeling Distal Tubules.
Grimm PR; Coleman R; Delpire E; Welling PA
J Am Soc Nephrol; 2017 Sep; 28(9):2597-2606. PubMed ID: 28442491
[TBL] [Abstract][Full Text] [Related]
20. MST3 Involvement in Na
Chan CH; Wu SN; Bao BY; Li HW; Lu TL
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
